Inactive Instrument
CannaVEST Corp Share Price OTC Bulletin Board
Stocks
US1376531018
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 14/08 | CV Sciences, Inc., Q2 2026 Earnings Call, Aug 13, 2026 | |
| 14/08 | CV Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 30.08L 26.73L 24.94L 22.74L 42.88L 29Cr 43.28L 3.02Cr 1.17Cr 15Cr 1.13Cr 1.1Cr 47Cr | P/E 2024 |
-2.48x | P/E 2025 | -11.8x |
|---|---|---|---|---|---|
| Enterprise Value | 47.26L 41.99L 39.19L 35.72L 67.37L 45Cr 68L 4.74Cr 1.84Cr 23Cr 1.77Cr 1.74Cr 75Cr | EV / Sales 2024 |
0.42x | EV / Sales 2025 | 0.95x |
| Free-Float |
78.62% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: CannaVEST Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
CEO | Chief Executive Officer | 68 | 31/05/2018 |
Joerg Grasser
DFI | Director of Finance/CFO | 51 | 15/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Dowling
BRD | Director/Board Member | 68 | 31/05/2018 |
Jamie Corroon
BRD | Director/Board Member | 56 | 21/07/2022 |
William McCorkle
BRD | Director/Board Member | 58 | 21/10/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.39% | -3.10% | +39.88% | +113.05% | 1,02500Cr | |
| -1.29% | -5.90% | +37.24% | +64.51% | 62TCr | |
| +1.15% | -0.72% | +10.94% | +77.03% | 46TCr | |
| +0.05% | -3.31% | +60.72% | +40.28% | 35TCr | |
| -0.95% | -4.05% | +21.60% | +39.37% | 34TCr | |
| -1.46% | -2.89% | +11.84% | +24.60% | 27TCr | |
| -1.35% | -5.43% | -4.69% | +8.40% | 25TCr | |
| -0.80% | -2.58% | +35.82% | +51.67% | 22TCr | |
| -1.93% | -4.43% | +30.46% | +94.66% | 18TCr | |
| Average | -0.80% | -1.89% | +27.09% | +57.06% | 41.31TCr | |
| Weighted average by Cap. | -0.62% | -2.11% | +30.50% | +68.95% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.57Cr 1.4Cr 1.3Cr 1.19Cr 2.24Cr 150.98Cr 2.26Cr 16Cr 6.11Cr 77Cr 5.9Cr 5.77Cr 247.7Cr | 1.38Cr 1.23Cr 1.14Cr 1.04Cr 1.97Cr 132.56Cr 1.98Cr 14Cr 5.36Cr 68Cr 5.18Cr 5.06Cr 217.48Cr |
| Net income | -23.94L -21.27L -19.85L -18.1L -34.13L -23Cr -34.44L -2.4Cr -93.1L -12Cr -89.88L -87.93L -38Cr | -10L -9L -8L -7L -13.66L -9.21Cr -13.78L -96.14L -37.25L -4.71Cr -35.97L -35.19L -15Cr |
| Net Debt | 3L 3L 3L 2L 5L 3.12Cr 5L 32.62L 12.64L 1.6Cr 12.2L 11.94L 5.13Cr | 17.18L 15.26L 14.25L 12.99L 24.49L 17Cr 24.72L 1.72Cr 66.81L 8.44Cr 64.5L 63.1L 27Cr |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
